BioRICS
ActiveSummary
BioRICS has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€104,780) and a net result of -€194,737. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 12% of 193 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability21▼-1
Solvency20▼-9
Growth32▼-20
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.17 against 0.23 in 2024; short-term debt: 95.6% and cash: 0.2% of total assets), and equity is negative.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-4.8%
Return on assets
-8.9%
Age of the figures
9 mo
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
18192122232425
2018 to 2025 · latest year -€104,780
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-08-2026, 7 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
7 d late
2024
35 d early
2023
90 d early
2022
63 d early
2021
69 d early
2019
11 d early
2018
27 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 33 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€194,737▲ 6.4%
2024 · -€208,082
Working capital
-€1.7m▼ 17.8%
2024 · -€1.5m
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result-€944,731--€791,236▲ 16.2%-€374,390▲ 52.7%-€144,152▲ 61.5%-€132,875▲ 7.8%
Net result-€947,223below the sector's middle half--€765,433below the sector's middle half▲ 19.2%-€412,754below the sector's middle half▲ 46.1%-€208,082below the sector's middle half▲ 49.6%-€194,737within the sector's middle half▲ 6.4%
Equity€1.5mabove the sector's middle half-€710,793within the sector's middle half▼ 51.9%€298,040within the sector's middle half▼ 58.1%€89,958within the sector's middle half▼ 69.8%-€104,780below the sector's middle half
Total assets€1.8mabove the sector's middle half-€1.5mwithin the sector's middle half▼ 14.9%€1.7mwithin the sector's middle half▲ 12.8%€2.3mwithin the sector's middle half▲ 35.8%€2.2mwithin the sector's middle half▼ 5.4%
Debt€293,798-€796,060▲ 171%€1.4m▲ 76.0%€2.2m▲ 58.3%€2.3m▲ 3.2%
Working capital€1.0m--€588,567-€1.1m▼ 89.1%-€1.5m▼ 32.9%-€1.7m▼ 17.8%
Solvency83.4%within the sector's middle half-47.2%within the sector's middle half▼ 36.2pp17.5%within the sector's middle half▼ 29.6pp3.9%below the sector's middle half▼ 13.6pp-4.8%below the sector's middle half▼ 8.7pp
Staff (FTE)2.2-3.8below the sector's middle half▲ 72.7%2.7below the sector's middle half▼ 28.9%2.4below the sector's middle half▼ 11.1%2.8below the sector's middle half▲ 16.7%
above
within
below
the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €132,875 in 2025 against €144,152 in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.2m
Fixed assets
€1.8m ▼ 0.9%
Current assets
€344,381 ▼ 23.8%
Key figures and ratios
EBITDA
€119,960▼
2024 · €156,090
Cash flow
€58,098▼
2024 · €92,159
Current ratio
0.17▼
2024 · 0.23
Debt to equity
-21.83▼
2024 · 24.65
ROA
-8.9%▲
2024 · -9.0%
Interest coverage
1.67▼
2024 · 1.75
Debt ≤ 1 year
€2.1m▲
2024 · €1.9m
Debt > 1 year
€38,699▼
2024 · €47,228
Income taxes
-€7,956▲
2024 · -€24,338
Staff costs
€248,084▼
2024 · €330,398
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 2,798 companies that looked in July 2024 the way this one looks now, 1.9% went bankrupt within 24 months and 90% are still going.
- Micro
- 20 years or older
- negative equity
- a small loss
1.9%
went bankrupt
6.0%
stopped otherwise
90%
still going
A further 2.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.3% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.6% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 2,798 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €270,474 | €237,203 | €330,398 | €248,084 | ▼ 24.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €42,323 | €96,846 | €168,912 | €300,241 | €252,836 | ▼ 15.8% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | -€87,198 | €0 | ▲ 100% |
| Other operating charges640/8 | - | €628 | €644 | €23,046 | €1,595 | ▼ 93.1% |
| Gross operating margin9900 | -€673,772 | -€423,288 | €32,369 | €422,335 | €369,639 | ▼ 12.5% |
| Operating profit (loss)9901 | -€944,731 | -€791,236 | -€374,390 | -€144,152 | -€132,875 | ▲ 7.8% |
| Financial income75/76B | - | €640 | €376 | €1,165 | €2,207 | ▲ 89.4% |
| Recurring financial income75 | €1,330 | €640 | €376 | €1,165 | €2,207 | ▲ 89.4% |
| Financial charges65/66B | - | €4,537 | €51,053 | €89,434 | €72,025 | ▼ 19.5% |
| Recurring financial charges65 | €3,742 | €4,537 | €51,053 | €89,434 | €72,025 | ▼ 19.5% |
| Profit (loss) for the period before taxes9903 | -€947,143 | -€795,133 | -€425,068 | -€232,420 | -€202,693 | ▲ 12.8% |
| Income taxes67/77 | €80 | -€29,700 | -€12,314 | -€24,338 | -€7,956 | ▲ 67.3% |
| Profit (loss) for the period9904 | -€947,223 | -€765,433 | -€412,754 | -€208,082 | -€194,737 | ▲ 6.4% |
| Profit (loss) for the period to be appropriated9905 | -€947,223 | -€765,433 | -€412,754 | -€208,082 | -€194,737 | ▲ 6.4% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.8m | €1.5m | €1.7m | €2.3m | €2.2m | ▼ 5.4% |
| Fixed assets21/28 | €537,157 | €1.4m | €1.5m | €1.9m | €1.8m | ▼ 0.9% |
| Intangible fixed assets21 | €530,052 | €1.4m | €1.5m | €1.9m | €1.8m | ▼ 0.8% |
| Tangible fixed assets22/27 | €7,105 | €9,660 | €6,480 | €1,722 | €0 | ▼ 100% |
| Plant, machinery and equipment23 | - | €889 | €546 | - | - | - |
| Furniture and vehicles24 | - | €8,771 | €5,934 | €1,722 | €0 | ▼ 100% |
| Financial fixed assets28 | - | €9,000 | €9,000 | €0 | - | - |
| Current assets29/58 | €1.2m | €126,308 | €162,270 | €452,077 | €344,381 | ▼ 23.8% |
| Stocks and contracts in progress3 | - | €11,299 | €5,625 | €0 | - | - |
| Stocks30/36 | - | €11,299 | €5,625 | €0 | - | - |
| Amounts receivable within one year40/41 | €78,418 | €100,930 | €128,125 | €348,840 | €305,267 | ▼ 12.5% |
| Trade receivables40 | - | €21,024 | €21,474 | €9,090 | €51,590 | ▲ 468% |
| Other amounts receivable41 | - | €79,906 | €106,651 | €339,750 | €253,677 | ▼ 25.3% |
| Cash at bank and in hand54/58 | €1.1m | €547 | €21,158 | €798 | €5,230 | ▲ 556% |
| Deferred charges and accrued income490/1 | - | €13,532 | €7,362 | €102,439 | €33,884 | ▼ 66.9% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.8m | €1.5m | €1.7m | €2.3m | €2.2m | ▼ 5.4% |
| Equity10/15 | €1.5m | €710,793 | €298,040 | €89,958 | -€104,780 | ▼ 216% |
| Contributions10/11 | €2.5m | €1.4m | €1.4m | €1.4m | €1.4m | = |
| Capital10 | - | €1.4m | €1.4m | €1.4m | €1.4m | = |
| Issued capital100 | - | €1.4m | €1.4m | €1.4m | €1.4m | = |
| Reserves13 | €61 | €130,061 | €130,061 | €130,061 | €130,061 | = |
| Non-distributable reserves130/1 | - | €61 | €130,061 | €130,061 | €130,061 | = |
| Legal reserve130 | - | €61 | €61 | €61 | €61 | = |
| Reserves not available under the articles1311 | - | - | €130,000 | - | - | - |
| Other1319 | - | - | - | €130,000 | €130,000 | = |
| Distributable reserves133 | - | €130,000 | - | - | - | - |
| Profit (loss) carried forward14 | -€1.0m | -€769,268 | -€1.2m | -€1.4m | -€1.6m | ▼ 14.0% |
| Amounts payable17/49 | €293,798 | €796,060 | €1.4m | €2.2m | €2.3m | ▲ 3.2% |
| Amounts payable after more than one year17 | €79,702 | €71,823 | €63,786 | €47,228 | €38,699 | ▼ 18.1% |
| Financial debts170/4 | - | €71,823 | €63,786 | €47,228 | €38,699 | ▼ 18.1% |
| Amounts payable within one year42/48 | €212,352 | €714,875 | €1.3m | €1.9m | €2.1m | ▲ 8.1% |
| Current portion of amounts payable after more than one year42 | - | €7,879 | €8,037 | €692,361 | €692,400 | = |
| Trade debts44 | €114,958 | €383,399 | €300,470 | €214,385 | €259,530 | ▲ 21.1% |
| Suppliers440/4 | - | €383,399 | €300,470 | €214,385 | €259,530 | ▲ 21.1% |
| Taxes, remuneration and social security45 | - | €23,588 | €16,749 | €40,664 | €91,323 | ▲ 125% |
| Taxes450/3 | - | €0 | - | €3,999 | €8,149 | ▲ 104% |
| Remuneration and social security454/9 | - | €23,588 | €16,749 | €36,664 | €83,174 | ▲ 127% |
| Other amounts payable47/48 | - | €300,010 | €950,010 | €983,380 | €1.0m | ▲ 6.1% |
| Accrued charges and deferred income492/3 | - | €9,361 | €62,092 | €239,473 | €161,884 | ▼ 32.4% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€947,223 | -€765,433 | -€412,754 | -€208,082 | -€194,737 | ▲ 6.4% |
| + Depreciation and write-downs630 | €42,323 | €96,846 | €168,912 | €300,241 | €252,836 | ▼ 15.8% |
| Operating cash flow (approximation) | -€904,900 | -€668,587 | -€243,842 | €92,159 | €58,098 | ▼ 37.0% |
| Investment in fixed assets (approximation) | - | -€940,233 | -€325,280 | -€618,700 | -€235,723 | ▲ 61.9% |
| Change in cash | - | -€1.1m | €20,611 | -€20,360 | €4,432 | ▲ 122% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
07-08
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 7 days late
2025
26-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2023
02-11
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2022
29-11
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2021
23-11
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
30-06
Financial
Weakest financial yearnet -€947,223
Net result drops to -€947,223, the lowest in the series; recovery starts the following year.
30-06
Financial
Liquidity times 66current ratio 5.81
Current ratio from 0.09 to 5.81; short-term debt falls from €419,838 to €212,352.
30-06
Financial
Equity above €1mEq €1.5m
Equity rises from -€239,053 to €1.5m.
2020
20-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
27-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 27 days late
2018
24-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 24 days late
2017
29-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 29 days late
2016
29-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 23 acts read
About the unread acts
We know of 23 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
23 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 2006
Ground area
5,741 m²
Building footprint
1,562 m²
Volume, LiDAR
14,818 m³
Parcel 24514C0032/00H000, Flanders · tallest building 11.8 m, ±3 floors. Linked by address, not a title deed.
16
companies at this address
See who is registered here
1 establishment unit
Biorics
since 20062.155.846.180
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24514C0032/00H000 | Flanders | 5,740 m² | 1 · 1,562 m² | 11.8 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 owner · 1 holdingOwners 1
-
23.82%
Holdings 1
- Biorics IncUSsubsidiarySourceown accounts 30-06-2023100%
According to the annual accounts to 30-06-2023 of BioRICS and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Public money · subsidies and aid
Flemish government
2022 to 2025 · 13 entries · 502,608 EUR awarded · 430,978 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 5 | 0 EUR | 99,978 EUR |
| 2024 | 2 | 435 EUR | 70,000 EUR |
| 2023 | 3 | 0 EUR | 132,000 EUR |
| 2022 | 3 | 502,173 EUR | 129,000 EUR |
Federal government
2024 to 2025 · 2 entries · 157,200 EUR in total| Year | Department | Transactions | Amount |
|---|---|---|---|
| 2025 | Defensie | 1 | 52,400 EUR |
| 2024 | Defensie | 1 | 104,800 EUR |
Budget allocations
European research
2 projects · 241,128 EUR EU contributionProgrammes
Projects
Mental Health promotion of cobot Workers in Industry 4.0
The European Platform to Promote Healthy Lifestyle and improve care through a Personal Persuasive Assistant
Similar companies · same sector, comparable size
EMELIE FLEMMING-PARKER
BE 0795.904.004
Tongeren-Borgloon · Eq €90,094
Fédération européenne des Ports intérieurs - Europese Vereniging van Binnenhavens
BE 0457.151.793
Brussel · Eq €89,360
Koios Care
BE 0786.830.148
Antwerpen · Eq €89,260
Digital Cell Imaging Labs
BE 0476.339.680
Keerbergen · Eq €89,193
CABINET MEDICAL CHAPMAN
BE 0812.150.415
Spa · Eq €89,015
Of 1,177 companies in sector 72109 we hold annual accounts for 717. 433 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded10-03-2006
Fiscal year end31-12
Activities, NACEBEL 2025
62100Computer programming
72109Other research and development on natural sciences
64210Activities of holding companies
68110Buying and selling of own real estate
68201Renting and operating of own or leased residential real estate, excluding social housing
70200Business and other management consultancy
E-invoicing
Reachable via Peppol
Peppol ID
0208:0880194826
Also
9925:BE0880194826
Registered
16-12-2025
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.